United Therapeutics Hits High After FDA Approval

By | December 23, 2013

Scalper1 News

United Therapeutics (UTHR) stock jumped to an all-time Monday in reaction to the company’s announcement late Friday of federal approval for its drug to treat hypertension. United Therapeutics stock was up more than 22% in morning trading in the stock market today, near 107.50. The stock has more than doubled in 2013 and has an IBD Relative Strength Rating of 85. Late Friday, the company said the Food and Drug Administration had approved its Scalper1 News

Scalper1 News